As of Jan 17
| -4.11 / -3.49%|
The 16 analysts offering 12-month price forecasts for Incyte Corp have a median target of 111.50, with a high estimate of 122.00 and a low estimate of 87.00. The median estimate represents a -1.88% decrease from the last price of 113.64.
The current consensus among 18 polled investment analysts is to Buy stock in Incyte Corp. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.